Question to the Department for Business, Energy and Industrial Strategy:

To ask the Secretary of State for Business, Energy and Industrial Strategy, if he will publish the (a) data, (b) evidence and (c) reasoning which supports the findings that the Valneva covid-19 vaccine in trial would not receive UK regulatory approval prior to the end of that trial.

The response given by my Rt. Hon. Friend the Secretary of State for Health and Social Care to a question raised by the hon. Member for Livingston (Hannah Bardell) has been clarified [1] to make clear that Valneva’s Covid-19 vaccine has not yet gained approval by the Medicines and Healthcare products Regulatory Agency (MHRA) here in the UK, and that the outcome of that approval process will be a matter for the MHRA once the trials have been concluded and the data has been submitted.

[1]https://hansard.parliament.uk/commons/2021-09-16/debates/E09C8E55-4307-43B6-B57E-BA2E9BFB556F/HealthAndSocialCare#10MC